Next Article in Journal
Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4
Next Article in Special Issue
Evaluation of Conspiracy Beliefs, Vaccine Hesitancy, and Willingness to Pay towards COVID-19 Vaccines in Six Countries from Asian and African Regions: A Large Multinational Analysis
Previous Article in Journal
Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2
Previous Article in Special Issue
Severity and Mortality Predictors of COVID-19 Patients with Thrombotic Events-Evidence from the “COVID-One” Hospital in Albania
 
 
Article

Article Versions Notes

Vaccines 2022, 10(11), 1853; https://doi.org/10.3390/vaccines10111853
Action Date Notes Link
article xml file uploaded 1 November 2022 09:21 CET Original file -
article xml uploaded. 1 November 2022 09:21 CET Update https://www.mdpi.com/2076-393X/10/11/1853/xml
article pdf uploaded. 1 November 2022 09:21 CET Version of Record https://www.mdpi.com/2076-393X/10/11/1853/pdf
article html file updated 1 November 2022 09:22 CET Original file -
article html file updated 5 November 2022 10:53 CET Update -
article html file updated 28 February 2023 20:57 CET Update -
article html file updated 2 March 2023 20:06 CET Update https://www.mdpi.com/2076-393X/10/11/1853/html
Back to TopTop